Renal Denervation Market Size is Expected to Reach at USD 4,465 Million by 2030, Registering a CAGR of 41.5%, Owing to Growing Prevalence of Hypertension
The Global Renal Denervation Market Size is predicted to reach USD 4,465 Million by 2030 from USD 198 Million in 2021, at a CAGR of 41.5% between 2022 and 2030, as per the Acumen Research and Consulting
The renal denervation market is a relatively new and evolving market. Renal denervation is a minimally invasive procedure that uses radiofrequency energy to reduce hypertension by modifying the sympathetic nerve activity in the renal artery. The procedure has been developed as an alternative to medication and other invasive procedures, such as renal artery stenosis, for treating hypertension. The renal denervation market is driven by factors such as the increasing prevalence of hypertension, the growing awareness about the procedure, and the benefits of the procedure over traditional treatments. Additionally, the development of new and advanced technologies, such as catheter-based systems, is also driving market growth.
However, the market is still in its early stages and faces several challenges such as a lack of long-term data on the safety and effectiveness of the procedure and reimbursement issues. Additionally, the market has experienced some setbacks in the past due to the negative results of clinical trials, which has led to a decrease in the adoption of the procedure. Despite these challenges, the market is expected to grow in the coming years as more data on the safety and effectiveness of the procedure becomes available and as new technologies are developed. Additionally, the increasing adoption of the procedure in emerging markets is also expected to drive market growth.
Renal Denervation Market Statistics
- Global renal denervation market revenue collected USD 198 Million in 2021, with a 41.5% CAGR between 2022 and 2030
- Europe renal denervation market value gathered more than USD 139 Million in 2021
- By product type, the symplicity category capture over 45% of total market share in 2021
- By technology, the radiofrequency segment captured the majority of the market
- Development of new and advanced technologies, such as catheter-based systems, fuels the renal denervation market size
Request for a sample of this premium research report@ https://www.acumenresearchandconsulting.com/request-sample/992
Renal Denervation Market Trends
The renal denervation market has undergone a significant revolution over the past few years. Initially, the market was primarily focused on catheter-based systems that used radiofrequency energy to ablate the renal sympathetic nerves. However, recent advancements in technology have led to the development of new and innovative methods for performing renal denervation, such as ultrasound-based systems and nerve-stimulation systems.
One of the major trends in the market has been the development of ultrasound-based systems, such as the Symplicity Spyral system from Medtronic, which uses high-frequency ultrasound energy to ablate the renal sympathetic nerves. This method has been shown to be less invasive and more effective than traditional catheter-based systems. Another major development in the market has been the development of nerve-stimulation systems, such as the Vercise system from Boston Scientific, which uses electrical stimulation to modify the activity of the renal sympathetic nerves. This method has been shown to be effective in treating hypertension and has the potential to be used for other indications as well. These advancements in technology have led to a renewed interest in renal denervation as a treatment for hypertension and have helped to establish the procedure as a viable alternative to traditional treatments.
Renal Denervation Market Segmentation
Acumen Research and Consulting has segmented the global renal denervation market by product type, indication, technology, and end-user.
- By product type, the industry is categorized into iberis, vessix, symplicity, paradise, enlightn, and others.
- By indication, the market is divided into renal failure, hypertension, diabetes, and heart failure.
- By technology, the market is classified into micro-infusion, radiofrequency, and ultrasound.
- By end-user, the market is bifurcate into specialty clinics, hospitals, and others.
Renal Denervation Market Regional Overview
The renal denervation market is divided into five geographic segments: Asia-Pacific, North America, Latin America, Europe, and the MEA. As per the renal denervation industry analysis, Europe is currently dominating the market. This growth is due to factors such as the high adoption of the procedure in the region, the presence of a huge number of key players in the region, and the availability of reimbursement for the procedure. Europe is expected to continue to dominate the market in the coming years, with countries such as Germany, France, and the United Kingdom being the major contributors to the region's market share. The high adoption of the procedure in these countries and the existence of a large number of key players in the region are some of the major factors driving the market growth in Europe.
Renal Denervation Market Players
Some of the major renal denervation market companies are Kona Medical, Inc., Mercator MedSystems, Inc., Cardiosonic, Inc., Abbott Laboratories, Renal Dynamics, ReCor Medical, Inc., Symple Surgical, Inc., Boston Scientific Corp., Medtronic PLC, and Ablative Solutions, Inc.
Click here to buy the Premium Market Research report https://www.acumenresearchandconsulting.com/buy-now/0/992
Receive our personalized services and customization by clicking here https://www.acumenresearchandconsulting.com/request-customization/992
Mr. Frank Wilson
Acumen Research and Consulting
USA: +13474743864
India: +918983225533